1.Effects of C-Reactive Protein and Fibrinogen on Activated Partial Thromboplastin Time and Anti Xa Activity in Extracorporeal Membrane Oxygenation Patients
Jing-shu FANG ; Fang-yan GAN ; Shuang DENG
Progress in Modern Biomedicine 2025;25(15):2524-2529
Objective:To investigate the effects of C-reactive protein(CRP)and fibrinogen(FIB)on activated partial thromboplastin time(APTT)and anti Xa activity in extracorporeal membrane oxygenation(ECMO)patients.Methods:The clinical data of 33 patients undergoing ECMO support treatment at Guangxi Zhuang Autonomous Region People's Hospital from January 2024 to July 2024 were retrospective analysis.Patients undergoing ECMO support treatment were divided into low-CRP group and high-CRP group.FIB,APTT and anti-Xa activity between low-CRP group and high-CRP group were compared.The correlation between APTT and anti-Xa activity in low-CRP group and high-CRP group were analyzed by Pearson method.Results:The APTT levels in the high CRP group was higher than that in the low CRP group(P<0.05).There was no statistically significant difference in anti Xa activity between the low CRP group and the high CRP group(P>0.05).The FIB levels in the high CRP group was higher than that in the low CRP group(P<0.05).The correlation between APTT and anti-Xa activity in the low-CRP group was positively correlated(r=0.698,P<0.05),while the correlation between APTT and anti-Xa activity in the high-CRP group was positively correlated(r=0.650,P<0.05),there was no strong in the correlation between APTT and anti-Xa activity between the low-CRP group and high-CRP group.Conclusion:Abnormal elevation of CRP levels can affect the detection of APTT in patients undergoing ECMO supportive therapy,but does not affect the detection of anti-Xa activity.The correlation between APTT and anti-Xa activity is not strong,so multiple monitoring indicators should be combined to comprehensively evaluate the anticoagulant efficacy of heparin.
2.Teaching Practice and Exploration of"Tutorial System"Based on The Cultivation of Scientific Research and Innovation Ability of Medical Students
Qiao ZHANG ; Yin-Feng YANG ; Yue-Li NI ; Zhuo-Ran TENG ; Wen-Jing LIU ; Jing WU ; Yan-Rui WU ; Yu DOU ; Ming HE ; Shu-De LI ; Ping GAN ; Fang YUAN ; Zhe YANG ; Xin-Wang YANG
Chinese Journal of Biochemistry and Molecular Biology 2025;41(3):470-480
The scientific research and innovation capabilities of medical students are intrinsically linked to the sustained and high-quality development of national healthcare initiatives.Cultivating outstanding medi-cal students with independent scientific capabilities and innovative consciousness is a critical component in the education and training of high-level medical professionals.Our investigation revealed that within the imperfections of the cultivating model,some faculty and students at medical schools have an insufficient understanding of scientific research and innovation and lack motivation for engaging in such activities,which hinder the progression of scientific research activities.Consequently,we initiated a teaching practice and exploratory study on the"tutorial system"aimed at fostering medical students'scientific research and innovation abilities.Based on the principle of"research informing teaching,teaching and research advan-cing together,"this study implements a"tutorial system"coordinated by tutors,supplemented by graduate and undergraduate student mentors,to cultivate innovative thinking,stimulate interest in scientific re-search,and enhance practical and research skills among medical students.Through collaborative efforts within"scientific research innovation teams,"various educational methods—including preliminary re-search,in-class and extracurricular activities,intra-group and inter-group interactions,and theoretical and practical applications—are employed to improve and strengthen the cultivation of medical students'scientif-ic research and innovation abilities.This study aims to provide valuable references for optimizing medical education management systems and enhancing the quality of medical student training.
3.Teaching Practice and Exploration of"Tutorial System"Based on The Cultivation of Scientific Research and Innovation Ability of Medical Students
Qiao ZHANG ; Yin-Feng YANG ; Yue-Li NI ; Zhuo-Ran TENG ; Wen-Jing LIU ; Jing WU ; Yan-Rui WU ; Yu DOU ; Ming HE ; Shu-De LI ; Ping GAN ; Fang YUAN ; Zhe YANG ; Xin-Wang YANG
Chinese Journal of Biochemistry and Molecular Biology 2025;41(3):470-480
The scientific research and innovation capabilities of medical students are intrinsically linked to the sustained and high-quality development of national healthcare initiatives.Cultivating outstanding medi-cal students with independent scientific capabilities and innovative consciousness is a critical component in the education and training of high-level medical professionals.Our investigation revealed that within the imperfections of the cultivating model,some faculty and students at medical schools have an insufficient understanding of scientific research and innovation and lack motivation for engaging in such activities,which hinder the progression of scientific research activities.Consequently,we initiated a teaching practice and exploratory study on the"tutorial system"aimed at fostering medical students'scientific research and innovation abilities.Based on the principle of"research informing teaching,teaching and research advan-cing together,"this study implements a"tutorial system"coordinated by tutors,supplemented by graduate and undergraduate student mentors,to cultivate innovative thinking,stimulate interest in scientific re-search,and enhance practical and research skills among medical students.Through collaborative efforts within"scientific research innovation teams,"various educational methods—including preliminary re-search,in-class and extracurricular activities,intra-group and inter-group interactions,and theoretical and practical applications—are employed to improve and strengthen the cultivation of medical students'scientif-ic research and innovation abilities.This study aims to provide valuable references for optimizing medical education management systems and enhancing the quality of medical student training.
4.Effects of C-Reactive Protein and Fibrinogen on Activated Partial Thromboplastin Time and Anti Xa Activity in Extracorporeal Membrane Oxygenation Patients
Jing-shu FANG ; Fang-yan GAN ; Shuang DENG
Progress in Modern Biomedicine 2025;25(15):2524-2529
Objective:To investigate the effects of C-reactive protein(CRP)and fibrinogen(FIB)on activated partial thromboplastin time(APTT)and anti Xa activity in extracorporeal membrane oxygenation(ECMO)patients.Methods:The clinical data of 33 patients undergoing ECMO support treatment at Guangxi Zhuang Autonomous Region People's Hospital from January 2024 to July 2024 were retrospective analysis.Patients undergoing ECMO support treatment were divided into low-CRP group and high-CRP group.FIB,APTT and anti-Xa activity between low-CRP group and high-CRP group were compared.The correlation between APTT and anti-Xa activity in low-CRP group and high-CRP group were analyzed by Pearson method.Results:The APTT levels in the high CRP group was higher than that in the low CRP group(P<0.05).There was no statistically significant difference in anti Xa activity between the low CRP group and the high CRP group(P>0.05).The FIB levels in the high CRP group was higher than that in the low CRP group(P<0.05).The correlation between APTT and anti-Xa activity in the low-CRP group was positively correlated(r=0.698,P<0.05),while the correlation between APTT and anti-Xa activity in the high-CRP group was positively correlated(r=0.650,P<0.05),there was no strong in the correlation between APTT and anti-Xa activity between the low-CRP group and high-CRP group.Conclusion:Abnormal elevation of CRP levels can affect the detection of APTT in patients undergoing ECMO supportive therapy,but does not affect the detection of anti-Xa activity.The correlation between APTT and anti-Xa activity is not strong,so multiple monitoring indicators should be combined to comprehensively evaluate the anticoagulant efficacy of heparin.
5.Experts consensus on standard items of the cohort construction and quality control of temporomandibular joint diseases (2024)
Min HU ; Chi YANG ; Huawei LIU ; Haixia LU ; Chen YAO ; Qiufei XIE ; Yongjin CHEN ; Kaiyuan FU ; Bing FANG ; Songsong ZHU ; Qing ZHOU ; Zhiye CHEN ; Yaomin ZHU ; Qingbin ZHANG ; Ying YAN ; Xing LONG ; Zhiyong LI ; Yehua GAN ; Shibin YU ; Yuxing BAI ; Yi ZHANG ; Yanyi WANG ; Jie LEI ; Yong CHENG ; Changkui LIU ; Ye CAO ; Dongmei HE ; Ning WEN ; Shanyong ZHANG ; Minjie CHEN ; Guoliang JIAO ; Xinhua LIU ; Hua JIANG ; Yang HE ; Pei SHEN ; Haitao HUANG ; Yongfeng LI ; Jisi ZHENG ; Jing GUO ; Lisheng ZHAO ; Laiqing XU
Chinese Journal of Stomatology 2024;59(10):977-987
Temporomandibular joint (TMJ) diseases are common clinical conditions. The number of patients with TMJ diseases is large, and the etiology, epidemiology, disease spectrum, and treatment of the disease remain controversial and unknown. To understand and master the current situation of the occurrence, development and prevention of TMJ diseases, as well as to identify the patterns in etiology, incidence, drug sensitivity, and prognosis is crucial for alleviating patients′suffering.This will facilitate in-depth medical research, effective disease prevention measures, and the formulation of corresponding health policies. Cohort construction and research has an irreplaceable role in precise disease prevention and significant improvement in diagnosis and treatment levels. Large-scale cohort studies are needed to explore the relationship between potential risk factors and outcomes of TMJ diseases, and to observe disease prognoses through long-term follw-ups. The consensus aims to establish a standard conceptual frame work for a cohort study on patients with TMJ disease while providing ideas for cohort data standards to this condition. TMJ disease cohort data consists of both common data standards applicable to all specific disease cohorts as well as disease-specific data standards. Common data were available for each specific disease cohort. By integrating different cohort research resources, standard problems or study variables can be unified. Long-term follow-up can be performed using consistent definitions and criteria across different projects for better core data collection. It is hoped that this consensus will be facilitate the development cohort studies of TMJ diseases.
6.Comparison of the validity of different self-rated tools for identifying (Hypo-) manic episodes mixed features: based on Date from the Second Phase of the National Bipolar Mania Clinical Pathway Survey
Zuowei WANG ; Yuncheng ZHU ; Chuangxin WU ; Guiyun XU ; Miao PAN ; Zhiyu CHEN ; Xiaohong LI ; Wenfei LI ; Zhian JIAO ; Mingli LI ; Yong ZHANG ; Jingxu CHEN ; Xiuzhe CHEN ; Na LI ; Jing SUN ; Jian ZHANG ; Shaohua HU ; Haishan WU ; Zhaoyu GAN ; Yan QIN ; Yumei WANG ; Yantao MA ; Xiaoping WANG ; Yiru FANG
Chinese Journal of Psychiatry 2024;57(7):426-432
Objective:A nationwide multi-center and large sample survey was conducted to compare the validity of the Mini International Neuropsychiatric Interview (Hypo-) Manic Episode with Mixed Features-DSM-5 Module (MINI-M) questionnaire and the Clinically Useful Depression Outcome Scale Supplemented with Questions for the DSM-5 Mixed Features Specifier (CUDOS-M) depression subscale in identifying mixed features in patients experiencing (hypo-) manic episodes.Methods:Using a convenience sampling method, 366 patients with bipolar disorder experiencing acute (hypo-) manic episodes who met the inclusion and exclusion criteria were recruited. The diagnosis of "with mixed features" was based on the DSM-5 criteria for mixed features. The predictive validity of the MINI-M questionnaire and the CUDOS-M depression subscale to screen mixed features was analyzed using the receiver operating characteristic (ROC) curve. Additionally, the difference in area under the ROC curve (AUC) between the two instruments was compared.Results:The AUC for the MINI-M questionnaire and the CUDOS-M depression subscale in screening mixed features were 0.79 (95 %CI=0.75-0.84) and 0.81 (95 %CI=0.77-0.86), respectively. There was no statistically significant difference in AUC between the two measurements ( Z=-1.19, P>0.05). Among patients with acute (hypo-) manic episodes, 45.9% (168/366) presented with mixed features according to the DSM-5 criteria, while the corresponding figures were 43.7% (160/366) using the MINI-M questionnaire (total score≥3) and 42.1% (154/366) using the CUDOS-M depression subscale (total score≥20). Screening results were comparable among the three measures. Conclusion:Mixed features are common among patients experiencing acute (hypo-) manic episodes. The MINI-M questionnaire and the CUDOS-M depression subscale demonstrate equivalent validity in identifying mixed features.
7.Comparison of the validity of different self-rated tools for identifying (Hypo-) manic episodes mixed features: based on Date from the Second Phase of the National Bipolar Mania Clinical Pathway Survey
Zuowei WANG ; Yuncheng ZHU ; Chuangxin WU ; Guiyun XU ; Miao PAN ; Zhiyu CHEN ; Xiaohong LI ; Wenfei LI ; Zhian JIAO ; Mingli LI ; Yong ZHANG ; Jingxu CHEN ; Xiuzhe CHEN ; Na LI ; Jing SUN ; Jian ZHANG ; Shaohua HU ; Haishan WU ; Zhaoyu GAN ; Yan QIN ; Yumei WANG ; Yantao MA ; Xiaoping WANG ; Yiru FANG
Chinese Journal of Psychiatry 2024;57(7):426-432
Objective:A nationwide multi-center and large sample survey was conducted to compare the validity of the Mini International Neuropsychiatric Interview (Hypo-) Manic Episode with Mixed Features-DSM-5 Module (MINI-M) questionnaire and the Clinically Useful Depression Outcome Scale Supplemented with Questions for the DSM-5 Mixed Features Specifier (CUDOS-M) depression subscale in identifying mixed features in patients experiencing (hypo-) manic episodes.Methods:Using a convenience sampling method, 366 patients with bipolar disorder experiencing acute (hypo-) manic episodes who met the inclusion and exclusion criteria were recruited. The diagnosis of "with mixed features" was based on the DSM-5 criteria for mixed features. The predictive validity of the MINI-M questionnaire and the CUDOS-M depression subscale to screen mixed features was analyzed using the receiver operating characteristic (ROC) curve. Additionally, the difference in area under the ROC curve (AUC) between the two instruments was compared.Results:The AUC for the MINI-M questionnaire and the CUDOS-M depression subscale in screening mixed features were 0.79 (95 %CI=0.75-0.84) and 0.81 (95 %CI=0.77-0.86), respectively. There was no statistically significant difference in AUC between the two measurements ( Z=-1.19, P>0.05). Among patients with acute (hypo-) manic episodes, 45.9% (168/366) presented with mixed features according to the DSM-5 criteria, while the corresponding figures were 43.7% (160/366) using the MINI-M questionnaire (total score≥3) and 42.1% (154/366) using the CUDOS-M depression subscale (total score≥20). Screening results were comparable among the three measures. Conclusion:Mixed features are common among patients experiencing acute (hypo-) manic episodes. The MINI-M questionnaire and the CUDOS-M depression subscale demonstrate equivalent validity in identifying mixed features.
8.Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer.
Jia-Luo HUANG ; Xue-Long YAN ; Dong HUANG ; Lu GAN ; Huahua GAO ; Run-Zhu FAN ; Shen LI ; Fang-Yu YUAN ; Xinying ZHU ; Gui-Hua TANG ; Hong-Wu CHEN ; Junjian WANG ; Sheng YIN
Acta Pharmaceutica Sinica B 2023;13(12):4934-4944
Nuclear transporter importin-β1 is emerging as an attractive target by virtue of its prevalence in many cancers. However, the lack of druggable inhibitors restricts its therapeutic proof of concept. In the present work, we optimized a natural importin-β1 inhibitor DD1 to afford an improved analog DD1-Br with better tolerability (>25 folds) and oral bioavailability. DD1-Br inhibited the survival of castration-resistant prostate cancer (CRPC) cells with sub-nanomolar potency and completely prevented tumor growth in resistant CRPC models both in monotherapy (0.5 mg/kg) and in enzalutamide-combination therapy. Mechanistic study revealed that by targeting importin-β1, DD1-Br markedly inhibited the nuclear accumulation of multiple CRPC drivers, particularly AR-V7, a main contributor to enzalutamide resistance, leading to the integral suppression of downstream oncogenic signaling. This study provides a promising lead for CRPC and demonstrates the potential of overcoming drug resistance in advanced CRPC via targeting importin-β1.
9.Analysis of clinical phenotypes of bipolar disorder with mixed states diagnosed using ICD-10 and DSM-5
Yang LI ; Jia ZHOU ; Zuowei WANG ; Yuncheng ZHU ; Guiyun XU ; Miao PAN ; Zhiyu CHEN ; Wenfei LI ; Zhian JIAO ; Mingli LI ; Yong ZHANG ; Jingxu CHEN ; Xiuzhe CHEN ; Na LI ; Jing SUN ; Jian ZHANG ; Shaohua HU ; Haishan WU ; Zhaoyu GAN ; Yan QIN ; Yumei WANG ; Yantao MA ; Xiaoping WANG ; Xiaohong LI ; Yiru FANG
Chinese Journal of Psychiatry 2023;56(4):267-275
Objective:This study investigates the difference in the detection rate and symptomatology between ICD-10 and DSM-5 diagnostic criteria for bipolar disorder with mixed states.Methods:Based on the Phase Ⅰ (2012) and Phase Ⅱ (2021) databases of National Bipolar Mania Pathway Survey (BIPAS), patients with bipolar disorder were included. General demographic data, clinical characteristics, symptomatic phenotypes, and mixed characteristics were retrieved. The detection rates and symptomatic performances of patients with or without mixed states in Phase Ⅰ and Ⅱ were compared using the chi-square test.Results:For patients with mixed states, the detection rate during Phase Ⅱ (2021) using DSM-5 (18.79%, 199/1 059) criteria was significantly higher than that during Phase Ⅰ (2012) using ICD-10 (6.78%, 199/2 934; χ 2=125.05, P<0.001). Whether using ICD-10 or DSM-5 criteria, patients with mixed states had a significantly higher frequency of multiple symptomatic manifestations. Conclusion:The DSM-5 diagnostic criteria generate a high detection rate for bipolar disorder with mixed states. The clinical phenotypes of bipolar disorder with mixed states vary significantly using different diagnostic tools.
10.Analysis of clinical phenotypes of bipolar disorder with mixed states diagnosed using ICD-10 and DSM-5
Yang LI ; Jia ZHOU ; Zuowei WANG ; Yuncheng ZHU ; Guiyun XU ; Miao PAN ; Zhiyu CHEN ; Wenfei LI ; Zhian JIAO ; Mingli LI ; Yong ZHANG ; Jingxu CHEN ; Xiuzhe CHEN ; Na LI ; Jing SUN ; Jian ZHANG ; Shaohua HU ; Haishan WU ; Zhaoyu GAN ; Yan QIN ; Yumei WANG ; Yantao MA ; Xiaoping WANG ; Xiaohong LI ; Yiru FANG
Chinese Journal of Psychiatry 2023;56(4):267-275
Objective:This study investigates the difference in the detection rate and symptomatology between ICD-10 and DSM-5 diagnostic criteria for bipolar disorder with mixed states.Methods:Based on the Phase Ⅰ (2012) and Phase Ⅱ (2021) databases of National Bipolar Mania Pathway Survey (BIPAS), patients with bipolar disorder were included. General demographic data, clinical characteristics, symptomatic phenotypes, and mixed characteristics were retrieved. The detection rates and symptomatic performances of patients with or without mixed states in Phase Ⅰ and Ⅱ were compared using the chi-square test.Results:For patients with mixed states, the detection rate during Phase Ⅱ (2021) using DSM-5 (18.79%, 199/1 059) criteria was significantly higher than that during Phase Ⅰ (2012) using ICD-10 (6.78%, 199/2 934; χ 2=125.05, P<0.001). Whether using ICD-10 or DSM-5 criteria, patients with mixed states had a significantly higher frequency of multiple symptomatic manifestations. Conclusion:The DSM-5 diagnostic criteria generate a high detection rate for bipolar disorder with mixed states. The clinical phenotypes of bipolar disorder with mixed states vary significantly using different diagnostic tools.

Result Analysis
Print
Save
E-mail